Iroquois Capital Management, LLC 13D and 13G filings for MyMD Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 11:27 am Purchase |
2023-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD |
Iroquois Capital Management, LLC | 168,853 4.990% |
109,815 (+186.01%) |
Filing |
| 2023-02-14 07:40 am Sale |
2022-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD |
Iroquois Capital Management, LLC | 59,038 6.470% |
-13,582 (-18.70%) |
Filing |
| 2022-02-23 4:45 pm Purchase |
2021-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD |
Iroquois Capital Management, LLC | 72,620 9.560% |
72,620 (New Position) |
Filing |